Skip to main content
NCBI home page
Clinical Epidemiology logoLink to Clinical Epidemiology
. 2018 Oct 26;10:1583–1598. doi: 10.2147/CLEP.S169302

Short- and long-term outcomes after postsurgical acute kidney injury requiring dialysis

Yu-Feng Lin 1,2, Tao-Min Huang 2,3, Shuei-Liong Lin 2,4, Vin-Cent Wu 2,✉, Kwan-Dun Wu 2
PMCID: PMC6208534  PMID: 30464638

Abstract

Objective

Prompt assessment of perioperative complications is critical for the comprehensive care of surgical patients. Acute kidney injury requiring dialysis (AKI-D) is associated with high mortality, yet little is known about how long-term outcomes of patients have evolved. The association of AKI-D with postsurgical outcomes has not been well studied.

Methods

We investigated patients from the National Health Insurance Research Database and validated by the multicenter Clinical Trial Consortium for Renal Diseases cohort. All patients with AKI-D 18 years or older undergoing four major surgeries (cardiothoracic, esophagus, intestine, and liver) were retrospectively investigated (N=106,573). Patient demographics, surgery type, comorbidities before admission, and postsurgical outcomes, including the in-hospital, 30-day, and long-term mortality together with dialysis dependence were collected.

Results

AKI-D is the top risk factor for 30-day and long-term mortality after major surgery. Of 1,664 individuals with AKI-D and 6,656 matched controls, AKI-D during the hospital stay was associated with in-hospital (adjusted hazard ratio [aHR]=3.04, 95% CI 2.79–3.31), 30-day (aHR=3.65, 95% CI 3.37–3.94), and long-term (aHR=3.22, 95% CI 3.01–3.44) mortality. Patients undergoing cardiothoracic surgery (CTS) showed less in-hospital (aHR=0.85, 95% CI 0.75–0.97), 30-day (aHR=0.79, 95% CI 0.70–0.89), and long-term (aHR=0.80, 95% CI 0.72–0.90) mortality compared with non-CTS patients with AKI-D. CTS patients had a high risk of 30-day dialysis dependence (subhazard ratio [sHR]=1.67, 95% CI 1.18–2.38), but the risk of long-term dialysis dependence was similar (sHR=1.38, 95% CI 0.96–2.00) after AKI-D by taking mortality as a competing risk. Non-CTS patients had more comorbidities of sepsis, azotemia, hypoalbuminemia, and metabolic acidosis compared with CTS patients.

Conclusion

AKI exhibits paramount effects on postsurgical outcomes that extend well beyond discharge from the hospital. The goal of the perioperative assessment should include the reassurance of enhancing renal function recovery among different surgeries, and optimized follow-up is warranted in attenuating the complications after postsurgical AKI has occurred.

Keywords: major surgery, acute kidney injury, postsurgical complication, dialysis dependence, mortality

Introduction

Acute kidney injury (AKI) is a severe perioperative complication.1,2 Although the incidence of postsurgical AKI depends immensely on the type of the surgery, up to 40% of hospital-acquired AKI is related to the perioperative setting.3,4 It is associated with prolonged hospital stay, increased costs, and both short- and long-term mortality.5–8 Among the patients with the most severe forms of AKI, those requiring dialysis (AKI-D) experience higher mortality9 and incur greater resource use.10,11 Additionally, postsurgical AKI is associated with long-term adverse events including mortality and the development of chronic kidney disease.12–14 AKI can be a reflection of the general insult of critical illness while also being an independent contributor to that illness; postsurgical AKI is of particular interest as a significant and measurable event of perioperative harm and a plausible target for intervention. Severe AKI after a major surgery is associated with a high risk of mortality and increased costs of care; this adverse impact might extend beyond the discharge of such surgical patients from the hospital.15

Recently, the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP)16 was established based on a “surgery-target” approach for improving risk-adjusted surgical outcomes and allowing highly detailed evaluations of performance and zero in on preventable complications.17,18 Because a growing movement aims to tie reimbursements to outcomes, the performance related to the influence of postsurgical AKI among different surgeries to in-hospital, 30-day, and long-term mortality as well as dialysis dependence is important for enhancing quality initiatives. To our knowledge, the association between surgical type and 30-day or long-term dialysis dependence together with the clinical significance of AKI episodes with respect to clinically relevant outcomes has not been comprehensively studied in a surgical patient population.

This study aimed to evaluate the influence of AKI-D on postsurgical in-hospital, 30-day, and long-term outcomes, including mortality and dialysis dependence, among patients who were undergoing different major surgeries. We investigated the association between AKI-D and outcomes while adjusting for surgery procedures, patient demographics, and comorbidities, using a large nationwide database and validated by prospectively enrolled nationwide cohort.

Methods

Data source

The National Health Insurance Research Database (NHIRD) of the National Health Insurance (NHI) program is mandatory and universal, offering comprehensive medical care coverage to more than 99% of the country’s population of 23 million people. The NHI system contains all original claims data, including demographic information and detailed orders, for all clinic visits and hospitalizations. Disease diagnoses for all individuals are classified according to the ICD, Ninth Revision, Clinical Modification (ICD-9-CM). Taiwan’s NHI records are regularly inspected, and physicians who violate the standards of clinical practice are subject to financial penalties.19 The accuracy of diagnoses registered in the NHIRD has been validated.20,21

For this study, patients (aged ≥18 years) who were admitted to the hospital from January 2001 to December 2007 for major surgery and who developed AKI-D during their index admission were identified in the NHI databases. Surgical procedures were considered major if the length of the intensive care unit (ICU) stay for patients in a given diagnosis-related group exceeded 2 days.22 Major surgery procedures were further classified into cardiothoracic, esophageal, intestinal, and hepatic as the primary diagnosis codes.4 We further divided all major surgeries into cardiothoracic surgery (CTS) and non-CTS. Because the identification numbers of all individuals in the NHRID were encrypted to protect the privacy of the individuals and informed consent was waived due to the secondary nature of the patient data, this study underwent limited ethical review by the Institutional Review Board of National Taiwan University Hospital (approval reference no. 201212021RINC).

Validation cohort

The Taiwan Consortium for Acute Kidney Injury and Renal Diseases (CAKS) from the National Research Program for Biopharmaceuticals has launched a nationwide epidemiology and prognostic program for tracking AKI-D, which prospectively enrolls critically ill patients with AKI-D in ICUs. CAKS includes 30-member hospitals that are widely distributed throughout the four geographical regions (north, middle, south, and east) of Taiwan. The CAKS member hospitals have a 1:1 ratio of medical centers to regional hospitals in each region and in the four seasonally sampled months (October 2014 and January, April, and July 2015).23 Patients undergoing dialysis after major surgery were selected to be in the validation cohort. This cohort included 79 CTS patients and 154 non-CTS patients. We used this cohort to validate different clinical manifestations and laboratory data between CTS patients and non-CTS patients during AKI-D. Detailed laboratory data and scoring systems were compared in each group of patients at ICU admission and the initiation of renal replacement therapy (RRT).

Data collection and outcome measures

Patient demographics, surgery type, Charlson comorbidity index, comorbidities before admission, and postsurgical outcomes including the in-hospital, 30-day, and long-term mortality together with dialysis dependence were reviewed from the database. The primary outcomes were in-hospital, 30-day, and long-term mortality after hospital discharge. The secondary outcomes were 30-day and long-term dialysis dependence defined as the requirement for dialysis for at least 3 months after hospital discharge, with mortality treated as a competing risk. Composite outcomes combined the outcomes of mortality and dialysis dependence. Each patient was monitored from the date of discharge to 30 days after discharge for 30-day mortality and was censored at either death or the end of the study (December 31, 2010) for long-term outcome, whichever occurred first.

Statistical analyses

We followed the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) recommendations for this study. After discharge, the status of dialysis dependence was integrated as a time-varying risk.

We performed a propensity score matching (PSM) to reduce the selection bias due to the baseline differences between the patients of AKI with dialysis and those of AKI without dialysis. First, we conducted multivariate logistic regression analysis to identify the predictors for the prescription of dialysis. Using logistic regression model, factors during the index hospitalization as predictors of AKI-D including age, sex, surgical type, hospital stay length, Charlson comorbidity index score, comorbidities, and postsurgical complications were identified as parameters for further PSM (Table S1 and Figures S2). Then, we used the “Match()” function in the “Matching” library of the R statistical software to do PSM based on the default value of “caliper” (ie, caliper = 0.25) and the Mahalanobis distance without replacement. After the matching, the standardized mean difference of all variables was <0.1 (Figure S2).

Patients who did not undergo acute dialysis during their index hospitalization but had a major surgery were matched to the study group at a 1:4 ratio after matching for age, sex, Charlson comorbidity index, and propensity score. We first modeled 30-day and long-term mortality using the occurrence of AKI-D after the surgery as the primary covariate of interest and adjusted for surgery type and preoperative covariates, including age, sex, Charlson comorbidity index, and individual comorbidities. However, cardiac surgery had the highest postoperative AKI risk.24 In addition, acute renal failure after cardiac surgery is known to be associated with significant short-term morbidity and mortality.25 In light of this, we constructed a second model stratifying AKI-D patients into CTS and non-CTS while adjusting the same preoperative covariates as the first model. In further parametric modeling with regard to factors associated with outcome, we adopted three modeling methods: simple Cox regression, multivariable Cox regression, and the competing risk regression. A Cox proportional regression model was used to calculate the adjusted hazard ratios (aHRs) and 95% CIs for the outcomes including in-hospital, 30-day, and long-term mortality and dialysis dependence. Because of high mortality and dialysis dependence rates in surgical patients with AKI-D, competing risk regression applying Fine and Gray modeling for consideration of the subdistribution hazard was performed to model dialysis dependence while treating mortality as a competing risk.26 Furthermore, the validation cohort was analyzed by PSM at a 1:1 ratio after matching for comorbidities and baseline demographics including age, sex, and severity scores. A bivariate analysis was performed using the t-test for normally distributed continuous variables and Wilcoxon rank-sum test for non-normally distributed continuous variables, and a chi-squared analysis was used for categorical variable comparisons and outcome events. Missing or invalid data on age, sex, and related variables were noted in 1.2% of the patients, and these patients were excluded from the analyses. We used R software, version 2.8.1 (Free Software Foundation, Inc., Boston, MA, USA); competing risk analysis was performed with Stata MP, version 12 (StataCorp, College Station, TX, USA). A two-sided P-value <0.05 was considered statistically significant.

Results

Data source and participants

From 2001 to 2007, 112,745 patients underwent major surgeries and 1,861 surgical patients with AKI-D during their index hospitalization were enrolled in the study (Figure 1). The incidence of AKI-D after major surgeries increased during this period, and the aHR of 30-day and long-term mortality also increased simultaneously (Figure S1 and Table S2). Compared with all the risk factors, AKI-D was the top risk factor for 30-day and long-term mortality (Table S3). With PSM at a 1:4 ratio, 8,320 surgical patients, 1,664 with AKI-D and 6,656 without dialysis were further analyzed.

Figure 1.

Figure 1

Open in a new tab

Study flow diagram.

Abbreviations: AKI, acute kidney injury; AKI-D, acute kidney injury requiring dialysis; AVF, arteriovenous fistula; ESRD, end-stage renal disease; RRT, renal replacement therapy.

Demographic characteristics, comorbidities, postsurgical complications, and outcomes

Baseline characteristics stratified by the AKI-D, surgery type, and comorbidities before and after the PSM are presented in Table 1. Of all patients undergoing major surgeries, the AKI-D group had the most underlying diseases and postsurgical comorbidities compared with the non-AKI-D group (Table 1). Besides, the surgical patients with AKI-D had higher in-hospital mortality compared with the non-AKI-D surgical patients (66.95% vs 5.37%). After the PSM (Table S1 and Figures S2), the surgical patients with AKI-D still had higher in-hospital mortality compared with the non-AKI-D surgical patients (68·87% vs 22·64%).

Table 1.

Basic demographic characteristics, comorbidities, complications, and outcomes in surgical patients stratified by AKI-D during the hospital stay

Characteristic All n=106,573 AKI-D n=1,861 Non-AKI-D n=104,712 SMD Propensity score-matched
AKI-D n=1,664 Non-AKI-D n=6,656 SMD
Male sex 60,847 (57.09%) 1,200 (64.48%) 59,647 (56.96%) 0.154 1,075 (64.60%) 4,440 (66.71%) −0.044
Age at admission 58.72±16.88 65.91±15.33 58.59±16.88 −0.454 65.67±15.62 66.56±14.71 0.058
Surgical type
 Cardiothoracic 20,335 (19.08%) 859 (46.15%) 19,476 (18.60%) −0.276 723 (43.45%) 3,033 (45.57%) 0.021
 Esophagus 18,268 (17.14%) 347 (18.65%) 17,921 (17.11%) −0.026 331 (19.89%) 1,239 (18.61%) −0.021
 Intestine 27,657 (25.95%) 404 (21.71%) 27,253 (26.03%) 0.077 372 (22.36%) 1,329 (19.97%) −0.043
 Liver 40,313 (37.83%) 251 (13.49%) 40,062 (38.26%) 0.575 238 (14.30%) 1,055 (15.85%) 0.042
Comorbidities (before admission)
 Myocardial infarction 1,658 (1.56%) 119 (6.39%) 1,539 (1.47%) 0.255 95 (5.71%) 394 (5.92%) −0.009
 Congestive heart failure 3,678 (3.45%) 283 (15.21%) 3,395 (3.24%) 0.423 226 (13.58%) 835 (12.55%) 0.031
 Peripheral vascular disease 807 (0.76%) 35 (1.88%) 772 (0.74%) 0.101 29 (1.74%) 166 (2.49%) −0.052
 Cerebrovascular disease 4,984 (4.68%) 141 (7.58%) 4,843 (4.63%) 0.124 119 (7.15%) 506 (7.60%) −0.017
 Dementia 1,074 (1.01%) 34 (1.83%) 1,040 (0.99%) 0.071 32 (1.92%) 155 (2.33%) −0.028
 COPD 9,318 (8.74%) 244 (13.11%) 9,074 (8.67%) 0.143 219 (13.16%) 929 (13.96%) −0.023
 Rheumatologic disease 612 (8.74%) 27 (13.11%) 585 (8.67%) 0.090 21 (1.26%) 96 (1.44%) −0.016
 Peptic ulcer disease 18,919 (17.75%) 326 (17.52%) 18,593 (17.76%) −0.006 289 (17.37%) 1,166 (17.52%) −0.004
 Mild liver disease 8,185 (7.68%) 175 (9.40%) 8,010 (7.65%) 0.063 153 (9.19%) 612 (9.19%) 0.000
 Diabetes 14,127 (13.26%) 546 (29.34%) 13,581 (12.97%) 0.409 452 (27.16%) 1965 (29.52%) −0.052
 Hemiplegia or paraplegia 409 (0.38%) 8 (0.43%) 401 (0.38%) 0.007 6 (0.36%) 28 (0.42%) −0.010
 Malignancy 4,405 (4.13%) 80 (4.30%) 4,325 (4.13%) 0.008 76 (4.57%) 275 (4.13%) 0.021
 Moderate or severe liver disease 897 (0.84%) 54 (2.90%) 843 (0.81%) 0.156 49 (2.94%) 176 (2.64%) 0.018
 AIDS 15 (0.01%) 0 (0.00%) 15 (0.01%) −0.017 0 (0.00%) 3 (0.05%) −0.030
 Charlson comorbidity index score 0.89±1.39 1.74±1.81 0.88±1.37 −0.537 1.59±1.72 1.69±1.87 0.057
 CKD 1,197 (1.12%) 218 (11.71%) 979 (0.93%) 0.454 130 (7.81%) 447 (6.72%) 0.042
Comorbidities (during index hospitalization)
 Pulmonary complications
  Reintubation 157 (0.14%) 40 (2.15%) 117 (0.11%) 0.194 29 (1.74%) 87 (1.31%) 0.036
  Acute respiratory distress syndrome 4,402 (4.13%) 738 (39.66%) 3,664 (3.50%) 0.979 603 (36.24%) 2,241 (33.67%) 0.054
  Pleural effusion 1,927 (1.81%) 78 (4.19%) 1,849 (1.77%) 0.143 71 (4.27%) 298 (4.48%) −0.010
  Chest tube insertion 3,536 (3.32%) 315 (16.93%) 3,221 (3.08%) 0.474 253 (15.20%) 952 (14.30%) 0.025
 Cardiac complications
  Hemopericardium 693 (0.65%) 37 (1.99%) 656 (0.63%) 0.120 33 (1.98%) 144 (2.16%) −0.013
  Hypovolemic shock 2,277 (2.14%) 268 (14.40%) 2,009 (1.92%) 0.468 223 (13.40%) 831 (12.48%) 0.027
  Cardiac arrest 51 (0.05%) 9 (0.48%) 42 (0.04%) 0.087 7 (0.42%) 16 (0.24%) 0.031
  Heart block 274 (0.26%) 11 (0.59%) 263 (0.25%) 0.053 8 (0.48%) 31 (0.47%) 0.002
  Atrial fibrillation 2,984 (2.80%) 92 (4.94%) 2,892 (2.76%) 0.114 81 (4.87%) 355 (5.33%) −0.021
  ECMO 5,050 (4.74%) 509 (27.35%) 4,541 (4.34%) 0.664 414 (24.88%) 1,692 (25.42%) −0.012
 Infectious complications
  Pneumonia 4,377 (4.11%) 355 (19.08%) 4,022 (3.84%) 0.493 293 (17.61%) 1,150 (17.28%) 0.009
  Urinary tract infection 2,504 (2.35%) 100 (5.37%) 2,404 (2.30%) 0.161 80 (4.81%) 386 (5.80%) −0.044
  Severe sepsis 2,533 (2.38%) 387 (20.80%) 2,146 (2.05%) 0.617 319 (19.17%) 1,220 (18.33%) 0.022
 Others
  Delirium 180 (0.17%) 5 (0.27%) 175 (0.17%) 0.022 5 (0.30%) 22 (0.33%) −0.005
  Stroke 1,198 (1.12%) 48 (2.58%) 1,150 (1.10%) 0.110 39 (2.34%) 157 (2.36%) −0.001
  GI bleeding 2,733 (2.56%) 142 (7.63%) 2,591 (2.47%) 0.237 123 (7.39%) 515 (7.74%) −0.013
Open in a new tab

Note: Data presented as n (%) or mean ± SD.

Abbreviations: AKI-D, acute kidney injury requiring dialysis; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; ECMO, extracorporeal membrane oxygenation; GI, gastrointestinal; SMD, standardized mean difference.

All-cause mortality after postsurgical AKI-D

After PSM, 8,320 surgical patients were analyzed using time-dependent Cox proportional hazard modeling, with dialysis dependence after hospital discharge as the time-varying risk. Similar results were obtained before and after PSM. After matching with the adjustment of baseline demographics, surgery type, Charlson comorbidity index, and comorbidities, postsurgical AKI-D augmented in-hospital (aHR: 3.04, 95% CI 2.79–3.31), 30-day (aHR: 3.65, 95% CI 3.37–3.94), and long-term (aHR: 3.22, 95% CI 3.01–3.44) mortality after a median follow-up of 294.5 days (Table 2).

Table 2.

Comparison of the in-hospital, 30-day, and long-term mortality in AKI-D vs non-AKI-D in surgical patients before and after propensity score matchinga

Mortality Events Person- years Incidence (per 1,000 person-years) Events Person- years Incidence (per 1,000 person-years) Crude hazard ratio (95% CI) Adjust hazard ratiob (95% CI)
AKI-D Non-AKI-D
Before matching In-hospital 1,084 90,201 12 4,066 1,707,808 2.4 3.64 (3.39–3.91) 3.37 (3.13–3.62)
30-day 1,246 109,626 11.4 5,616 4,698,184 1.2 7.63 (7.13–8.16) 6.03 (5.64–6.45)
Long-term 1,439 503,341 2.9 24,197 104,893,286 02 8.72 (8.26–9.20) 5.79 (5.48–6.11)
AKI-D Non-AKI-D
After matching In-hospital 1,006 74,417 13.5 1,161 256,992 4.5 3.00 (2.76–3.27) 3.04 (2.79–3.31)
30-day 1,146 90,744 12.6 1,507 415,220 3.6 3.58 (3.31–3.87) 3.65 (3.37–3.94)
Long-term 1,300 436,476 3 3,065 4,179,988 0.7 3.08 (2.88–3.29) 3.22 (3.01–3.44)
Open in a new tab

Notes:

a

This model showed good validity, with the adjusted generalized R2 and the concordance index being 0.4142 and 0.86, respectively.

b

Adjusted by age, sex, surgery type, Charlson comorbidity index, and individual comorbidities.

Abbreviation: AKI-D, acute kidney injury requiring dialysis.

Competing risk models of the outcomes

The competing risk model for stratifying AKI-D patients into CTS and non-CTS patients was additionally adjusted for age, sex, Charlson comorbidity index, individual comorbidities, and propensity score. We found similar results before and after PSM. After the matching, patients who underwent CTS had lower in-hospital (aHR: 0.85, 95% CI 0.75–0.97), 30-day (aHR: 0.79, 95% CI 0.70–0.89), and long-term mortality (aHR: 0.80, 95% CI 0.72–0.90); higher 30-day dialysis dependence (competing subhazard ratio [sHR]: 1.67, 95% CI 1.18–2.38); and similar long-term dialysis dependence (sHR: 1.38, 95% CI 0.96–2.00) compared with non-CTS patients after accounting for mortality as a competing risk (Table 3 and Figure 2). Furthermore, CTS patients had better 30-day (aHR: 0.85, 95% CI 0.76–0.96) and long-term (aHR: 0.81, 95% CI 0.73–0.91) composite outcome than non-CTS patients (Table 3).

Table 3.

Comparison of the in-hospital, 30-day, and long-term mortality and dialysis dependence in AKI-D patients undergoing CTS vs non-CTS before and after propensity score matching

Outcome Events Person-years Incidence (per 1,000 person-years) Events Person- years Incidence (per 1,000 person-years) Crude hazard ratio (95% CI) Adjust hazard ratioa (95% CI) Compete subhazard ratio (95% CI)
CTS Non-CTS
Before In-hospital mortality 435 42,204 10.3 649 47,997 13.5 0.77 (0.68–0.87) 0.79 (0.70–0.89) NA
matching 30-day dialysis 98 50,940 1.9 76 54,404 1.4 1·33 (0.99–1.80) 1.29 (0.95–1.75) 1.53 (1.13–2.08)
30-day mortality 500 53,395 9.4 746 56,231 13.3 0.72 (0.65–0.81) 0.74 (0.66–0.83) NA
30-day composite outcome 595 50,940 11.7 818 54,404 15 0.79 (0.71–0.88) 0.80 (0.72–0.89) NA
Long-term dialysis 85 204,271 0.4 75 185,973 0.4 1.07 (0.78–1.46) 0.99 (0.72–1.36) 1.28 (0.93–1.75)
Long-term mortality 605 258,081 2.3 834 245,260 3.4 0.74 (0.67–0.82) 0.77 (0.69–0.86) NA
Long-term composite outcome 661 204,271 3.2 885 185,973 4.8 0.76 (0.68–0.84) 0.78 (0.70–0.86) NA
CTS Non-CTS
After In-hospital mortality 380 31,598 12 626 42,819 14.6 0.84 (0.74–0.95) 0.85 (0.75–0.97) NA
matching 30-day dialysis 72 38,732 1.9 59 48,684 1.2 1.51 (1.07–2.13) 1.49 (1.05–2.11) 1.67 (1.18–2.38)
30-day mortality 433 40,590 10.7 713 50,154 14.2 0.77 (0.69–0.87) 0.79 (0.70–0.89) NA
30-day composite outcome 503 38,732 13 769 48,684 15.8 0.84 (0.75–0.94) 0.85 (0.76–0.96) NA
Long-term dialysis 62 174,374 0.4 58 176,277 0.3 1.15 (0.80–1.64) 1.10 (0.77–1.59) 1.38 (0.96–2.00)
Long-term mortality 512 211,117 2.4 788 225,359 3.5 0.77 (0.69–0.86) 0.80 (0.72–0.90) NA
Long-term composite outcome 551 174,374 3.2 828 176,277 4.7 0.79 (0.70–0.87) 0.81 (0.73–0.91) NA
Open in a new tab

Notes:

a

Adjusted by age, sex, Charlson comorbidity index, and individual comorbidities.

Abbreviations: CTS, cardiothoracic surgery; NA, not applicable.

Figure 2.

Figure 2

Open in a new tab

The mortality and competing risks regression of cumulative subhazard for dialysis dependence among different surgeries in 8,320 propensity score-matched surgical patients.

Notes: The hazard of short- and long-term mortality in different surgeries was shown in (A) and (B). The subhazard of short- and long-term dialysis dependence was shown in (C) and (D), while taking mortality as a competing risk.

Abbreviation: CTS, cardiothoracic surgery.

Clinical manifestations of postsurgical AKI

More detailed laboratory data of CTS and non-CTS patients were compared across all hospitals in the CAKS cohort23 for the validation of different clinical manifestations at postsurgical AKI during hospitalization. After PSM at a 1:1 ratio (Table S4), 144 patients (72 CTS patients, 72 non-CTS patients) were further analyzed. Non-CTS patients had more comorbidities of sepsis and azotemia during index hospitalization, together with more hypoalbuminemia and more metabolic acidosis compared with CTS patients (Table 4). Furthermore, non-CTS patients tend to receive intermittent hemodialysis, while CTS patients tend to receive continuous venovenous hemofiltration during acute kidney injury requiring dialysis (Table 4).

Table 4.

The comparison between CTS and non-CTS patients after propensity score matching in NEP-AKI-D study23 database

CTS n=79 Non-CTS n=154 SMD Propensity score-matched
CTS n=72 Non-CTS n=72 SMD
Comorbidities (during index hospitalization)
 Sepsis 40 (50.63%) 129 (83.77%) 0.750 36 (50.00%) 62 (86.11%) 0.834
 Azotemia 26 (32.91%) 78 (50.65%) 0.364 22 (30.56%) 35 (48.61%) 0.402
 Fluid overload 54 (68.35%) 113 (73.38%) 0.110 48 (66.67%) 52 (72.22%) 0.089
 Electrolyte imbalance 25 (31.65%) 47 (30.52%) 0.024 22 (30.56%) 21 (29.17%) 0.030
 Acid–base imbalance 26 (32.91%) 74 (48.05%) 0.311 25 (34.72%) 31 (43.06%) 0.170
 Uremia 3 (3.80%) 6 (3.90%) 0.005 3 (4.17%) 2 (2.78%) 0.075
 Oliguria 55 (69.62%) 109 (70.78%) 0.002 52 (72.22%) 57 (79.17%) 0.128
Laboratory data
 At initiation of RRT
  Glasgow coma scale 8.63±4.22 8.31±3.90 0.079 8.65±4.36 8.32±3.78 0.108
  PaO2/FiO2 272.49±180.28 295.34±190.09 0.123 281.89±184.93 296.17±196.90 0.122
  Mean arterial pressure 80.59±17.96 82.16±21.17 0.080 80.38±18.64 81.20±22.18 0.065
  Serum PH 7.37±0.11 7.34±0.12 0.261 7.37±0.11 7.36±0.12 0.089
  Serum HCO3 20.60±5.06 17.74±6.18 0.507 20.41±5.16 18.20±5.20 0.403
  Albumin 2.95±0.65 2.58±0.66 1.123 2.96±0.67 2.64±0.72 1.382
  Total bilirubin 2.19±3.70 3.38±6.65 0.220 2.25±3.86 3.37±5.83 0.229
  Aspartate aminotransferase 457.30±1,227.30 593.83±1,625.58 2.535 473.88±1,277.13 429.89±1,009.50 2.626
  Na 142.57±7.53 139.72±8.41 0.357 142.48±7.65 139.04±8.16 0.405
  K 4.42±0.97 4.62±1.08 0.193 4.45±0.95 4.62±1.01 0.131
  White blood cell count 12,777.22±6,311.08 14,052.93±8,926.50 0.165 12,990.97±6,397.34 14,055.69±8,219.88 0.137
  Blood urine nitrogen 62.50±43.55 79.56±45.49 0.383 61.17±44.46 78.17±41.37 0.408
  Creatinine 3.53±2.04 5.04±2.94 0.597 3.44±1.77 4.92±2.28 0.700
  Urine output 547.44±671.81 504.50±872.12 0.055 536.08±683.60 417.81±561.45 0.115
  Lactic acid 5.35±4.95 5.90±6.31 1.749 4.64±4.68 5.78±7.13 1.703
 RRT modalities 0.260 0.334
  CVVH 42 (85.71%) 48 (31.17%) 37 (51.39%) 18 (25.00%)
  SLEDD/SLEDD-f 4 (5.06%) 7 (4.55%) 4 (5.56%) 5 (6.94%)
  IHD 26 (32.91%) 84 (54.55%) 24 (33.33%) 40 (55.56%)
  Mix methods 7 (8.86%) 15 (9.74%) 7 (9.72%) 9 (12.50%)
Hospital stay length 42.20±35.57 44.13±34.78 0.055 41.51±36.15 45.58±36.98 0.127
Short-term mortality 42 (53.16%) 93 (60.39%) 0.146 37 (51.39%) 43 (59.72%) 0.139
Long-term mortality 46 (58.23%) 104 (67.53%) 0.193 41 (56.94%) 48 (66.67%) 0.170
Long-term survival with renal function recovery 26 (32.91%) 38 (24.68%) 0.182 25 (34.72%) 16 (22.22%) 0.245
Open in a new tab

Note: Data presented as n (%) or mean ± SD.

Abbreviations: CTS, cardiothoracic surgery; CVVH, continuous venovenous hemofiltration; IHD, intermittent hemodialysis; NEP-AKI-D, nationwide epidemiology and prognosis of dialysis-requiring acute kidney injury; non-CTS, noncardiothoracic surgery; RRT, renal replacement therapy; SLEDD, sustained low-efficiency daily dialysis; SLEDD-f, sustained low-efficiency daily diafiltration; SMD, standardized mean difference.

Discussion

Postsurgical AKI-D was associated with in-hospital, 30-day, and long-term mortality in patients undergoing major surgeries. In the analysis of surgery type, AKI-D patients who underwent CTS had lower in-hospital, 30-day, and long-term mortality compared with patients who had other types of surgeries. However, CTS patients with AKI-D had a higher risk of 30-day dialysis dependence but a similar risk of long-term dialysis dependence compared with non-CTS patients. This study showed that AKI-D in CTS and non-CTS patients had different clinical manifestation, mortality, and dialysis dependence patterns during hospitalization and even after hospital discharge, and thus should have different multidisciplinary teams to facilitate the implementation of enhanced recovery pathways.27 Because the incidence of AKI-D after major surgeries has increased in recent years,28 these findings provide a future direction of study for solving the unmet need of improving the mortality and outcomes in patients undergoing major surgeries with AKI-D. Furthermore, these results have significant implications for considering prevention strategies regarding different pathophysiology in the perioperative care of the patient undergoing major surgeries who has AKI-D.

In a study using data from the Ontario, Canada, universal health care databases to examine consecutive patients who had major elective surgery between 1995 and 2009, the incidence of AKI-D increased from 0.2% in 1995 to 0.6% in 2009 while 42% died within 90 days of surgery with no change in 90-day survival overtime and no change in chronic dialysis overtime among the patients surviving beyond 90 days.29 Lenihan et al examined AKI-D trends in a nationwide inpatient sample of individuals 75 years or older admitted for cardiac surgery. They found that the risk of AKI-D was significantly higher in 2008 than in 1999 (OR, 2.23; 95% CI 1.78–2.80), and the attributable risks for in-hospital mortality associated with AKI-D increased from 5% in 1999 to 14% in 2008.30 Compared with these studies, we studied longer-term outcomes than in-hospital or 90-day mortality and found an increased chance of post-surgical AKI-D together with increased long-term mortality overtime.29,30 The growing incidence of AKI-D may be due to a heightened awareness and better detection of AKI with the introduction of the RIFLE (risk, injury, failure, loss, end-stage renal disease) criteria in 200331 and the AKIN (acute kidney injury network) criteria32 for AKI or the postsurgical cooperation of new RRT technology such as continuous RRT. However, even with adjustment for the higher burden of comorbid conditions and complications, the hazard ratio for mortality increased over the years, and this may be due to the shift toward more complex and higher risk procedures on sicker patients.33

The novel finding of our study is that post-CTS patients with AKI-D have lower in-hospital, 30-day, and long-term mortality than non-CTS patients. This finding fills important gaps in previous research. Because AKI-D is a perilous postsurgical complication associated with increased risk of mortality, dialysis dependence, resource utilization, and cost,8,34 action is urgently required to increase awareness of and to prevent AKI in patients undergoing different major surgeries and to facilitate renal recovery as early as possible to decrease mortality. Our study extends this finding by providing an overview of all surgical patients including CTS and non-CTS patients with the most severe form of AKI, AKI-D. CTS increases the likelihood of ischemia–reperfusion injury that temporarily compromises renal perfusion and causes renal dysfunction,35 the so-called cardiorenal syndrome type 1 in which patients are more likely to be weaned from dialysis.36 Additionally, our study confirms recent findings that a substantial percentage of AKI-D survivors stay dialysis-dependent after the acute phase of their illness has resolved.37,38 Even with lower mortality in CTS patients, this finding serves as an impetus to develop greatly needed measures that protect and restore kidney function as soon as possible after AKI-D.

This study provides updated evidence of the epidemiology of AKI in surgical patients together with mortality and dialysis dependence data, which is the missing puzzle piece for the quality control of surgical efficacy and performance in public health. Moreover, the results support the renal angina concept that AKI can be stratified into different surgery type categories.39,40 Efforts of hemodynamic manipulations and close attention to intravenous resuscitation strategies including goal-directed therapy cannot be neglected to reduce AKI following major surgeries and its influence on postsurgical complications.41

These results provide direction for more personalized evaluation and optimized follow-up, taking into account surgery-specific characteristics. These findings also reinforce the importance of perioperative risk stratification for kidney injury and the implementation of strategies available to help prevent postsurgical AKI and long-term dialysis dependence. Furthermore, the findings indicate the potential for therapeutic interventions to attenuate the high burden of death and dialysis dependence after postsurgical AKI has occurred.

Strengths and limitations

A major strength of this study is the use of a large nationally representative database with exceptionally long renal followup; this gives us the ability to generalize and extrapolate the data with greater confidence. The NHIRD data are trustworthy because the database undergoes periodic detailed medical chart reviews and medical charge audits by professionals.42 The main limitation of our study is the lack of laboratory results for the national administrative dataset, leading to the possibility of residual confounding. Stricter control for estimated glomerular filtration rate or chronic kidney disease stage is crucial to derive more meaningful information. Besides, the CAKS database only included patients from ICU and that might bias our finding. Nevertheless, we validated the results in a different database with detailed laboratory data, and the results were similar in proving different manifestations in CTS and non-CTS patients in AKI. Furthermore, because this study was a retrospective observational analysis, a causal inference could not be derived. We did not assess the effect of the hospital- and surgeon-related factors such as hospital volume, location, emergent or elective surgery, prescribing physician, and level of experience. For the avoidance of the clustering effect, we used PSM together with multivariate adjustments and evaluated the model discrimination; we also attempted to increase the internal validity by using competing risk models.43,44 Because a high percentage of patients die after surgical AKI, we used competing risk analysis to examine the potential long-term dialysis dependence that would avoid confounding due to the “Will Rogers effect” of stage migration.45 Ours is also the first study to provide valuable long-term information related to kidney recovery following postsurgical AKI, given that follow-up for renal function recovery is almost nonexistent in recent clinical practice. Finally, while other investigators focused on the mortality issues in the specified surgical field having AKI, our results may provide data useful for generalized policy and practice frameworks for the proper perioperative care and future medical resource allocation.46

Conclusions

As the public health and economic burdens of surgery-related complications continue to grow, recognizing the entity of outpatient target-organ dysfunction is critical. Outpatient dialysis dependency is a pivotal clinical entity of postsurgical complications. In this nationwide population cohort of 106,573 surgical patients with AKI-D, we demonstrated an independent association between AKI-D and in-hospital, 30-day, and long-term mortality risk. Furthermore, CTS patients who have a high incidence of AKI-D have a lower risk of in-hospital, 30-day, and long-term mortality. Nonetheless, patients with CTS-related AKI-D had a higher risk of 30-day dialysis dependency, although their potential for long-term dialysis dependence was similar to that of patients with non-CTS AKI-D. In an era of increasing focus on patient-centered care, as well as continued reimbursement and quality improvement pressure, increased consideration for the management of renal function recovery toward an optimal team-based coordinated care after postsurgical AKI as an outpatient is warranted. The appropriate transition of patients undergoing surgery to follow-up in the outpatient setting with an emphasis on the renal function recovery and mitigation of mortality risk is justifiable in enhancing the care of the high-risk patients undergoing major surgeries. Physicians and policymakers should be aware of these results to access possible benefits of earlier initiation of recovery pathways and identify how to effectively reduce mortality and dialysis dependence for better perioperative management and thereby improve quality and reduce costs.

Supplementary materials

Figure S1

The trend of yearly AKI-D incidence in 106,573 surgical patients and an annually adjusted hazard ratio of 30-day and long-term mortality in 1,861 surgical AKI-D patients, stratified by the surgical type.

Notes: The annual incidence of AKI-D was shown in (A) and was compared in different surgical types in (B). The adjusted hazard ratio of 30-day mortality of surgical AKI-D patients was shown in (C) and was compared in different surgical types in (D), while the adjusted hazard ratio of long-term mortality of surgical AKI-D patients was shown in (E) and was compared in different surgical types in (F). The incidence of AKI-D increased from 1.16% in 2001 to 1.75% in 2007 (trend P≤0.001) (Figure S1A). The adjusted hazard ratio for 30-day mortality increased from 7.7 (95% CI 6.35–9.35) in 2001 to 9.19 (95% CI 7.82–10.9) in 2007 (Figure S1C), and long-term mortality increased from 7.2 (95% CI 6.12–8.48) in 2001 to 10.04 (95% CI 8.69–11.61) in 2007 (Figure S1E). Post-CTS patients had a higher incidence of AKI-D compared with non-CTS patients (Figure S1B). However, the 30-day and long-term mortality were higher in non-CTS patients (Figure S1D and F). **P<0·001.

Abbreviations: AKI-D, acute kidney injury requiring dialysis; CTS, cardiothoracic surgery.

clep-10-1583s1.tif (492.6KB, tif)
Figure S2

The standardized mean difference (SMD) of the variables before and after the propensity score matching. After the matching, the SMD of all variables was <0.1.

Abbreviations: CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; ECMO, extracorporeal membrane oxygenation; GI, gastrointestinal.

clep-10-1583s2.tif (281.1KB, tif)

Table S1.

Factors identified as predictors of AKI-D during index admission for the propensity score matchinga

Predictive variables Odds ratio (95% CI) P-value
Advanced CKD 32.740 (20.191–53.509) <0.001b
Cardiac arrest 5.115 (1.966–12.221) <0.001b
Use of ECMO 4.993 (4.236–5.890) <0.001b
Acute respiratory distress syndrome 4.860 (4.240–5.567) <0.001b
Hypovolemic shock 3.472 (2.944–4.083) <0.001b
Hospital stay length 3.320 (2.961–3.722) <0.001b
Repeat intubation 1.733 (1.123–2.622) 0.011b
Chest tube insertion 1.691 (1.443–1.976) <0.001b
Severe sepsis 1.624 (1.341–1.963) <0.001b
Rheumatologic disease 1.621 (1.023–2.466) 0.031b
Hemopericardium 1.449 (0.973–2.099) 0.058
Prolonged mechanical ventilation 1.397 (1.254–1.556) <0.001b
GI bleeding 1.382 (1.120–1.694) 0.002b
Charlson comorbidity index score 1.307 (1.235–1.383) <0.001b
Diabetes 1.279 (1.112–1.471) 0.001b
Surgical type (CVS vs others) 1.200 (1.034–1.389) 0.016b
Sex 1.101 (0.989–1.226) 0.079
Age 1.009 (1.005–1.012) <0.001b
Pneumonia 0.832 (0.692–0.998) 0.049b
Pleural effusion 0.734 (0.560–0.950) 0.022b
Myocardial infarction 0.693 (0.539–0.884) 0.004b
Atrial fibrillation 0.687 (0.530–0.879) 0.004b
Cerebrovascular disease 0.623 (0.502–0.767) <0.001b
Chronic obstructive pulmonary disease 0.563 (0.474–0.666) <0.001b
Dementia 0.557 (0.373–0.806) 0.003b
Hemiplegia or paraplegia 0.330 (0.135–0.698) 0.007b
Malignancy 0.328 (0.236–0.452) <0.001b
Open in a new tab

Notes:

a

Goodness of fit test: variance inflation faction of all factors (all <2); adjust generalized R2=0.295; area under the receiver operating characteristic curve=0.906 (0.899–0.913); this model does not pass the modified Hosmer–Lemeshow test.

b

P<0.05.

Abbreviations: AKI-D, acute kidney injury requiring dialysis; CKD, chronic kidney disease; CVS, cardiovascular surgery; ECMO, extra-corporeal membrane oxygenation; GI, gastrointestinal.

Table S2.

Incidence of AKI-D and its related crude mortality in 106,573 surgical patients stratified by four major surgeries

Patients Surgery type 2001 2002 2003 2004 2005 2006 2007 Total P for trend
Patient numbers All 14,424 14,886 13,615 15,328 15,775 16,212 16,333 106,573
Cardiothoracic 2,037 2,120 1,937 2,969 3,738 3,753 3,781 20,335
Esophagus 2,964 3,123 2,909 2,663 2,315 2,194 2,100 18,268
Intestine 3,644 3,962 3,700 3,920 4,082 4,142 4,207 27,657
Liver 5,779 5,681 5,069 5,776 5,640 6,123 6,245 40,313
AKI-D, n (%) All 167 (1.16) 196 (1.32) 194 (1.43) 249 (1.62) 344 (2.18) 376 (2.32) 335 (2.05) 1,861 (1.75)
Cardiothoracic 30 (1.47) 60 (2.83) 50 (2.58) 120 (4.04) 188 (5.03) 212 (5.65) 199 (5.26) 859 (4.22) <0.001
Esophagus 53 (1.79) 43 (1.38) 57 (1.96) 37 (1.39) 55 (2.38) 58 (2.64) 44 (2.10) 347 (1.90) 0.008
Intestine 54 (1.48) 61 (1.54) 56 (1.51) 54 (1.38) 53 (1.30) 73 (1.76) 53 (1.26) 404 (1.46) 0.661
Liver 30 (0.52) 32 (0.56) 31 (0.61) 38 (0.66) 48 (0.85) 33 (0.54) 39 (0.62) 251 (0.62) 0.378
Mortality in AKI-D, n (%) All 133 (79.64) 132 (67.35) 134 (69.07) 161 (64.66) 224 (65.12) 244 (64.89) 218 (65.07) 1246 (66.95)
Cardiothoracic 22 (73.33) 30 (50.00) 30 (60.00) 70 (58.33) 110 (58.51) 122 (57.55) 116 (58.29) 500 (58.21) 0.789
Esophagus 46 (86.79) 33 (76.74) 46 (80.70) 27 (72.97) 46 (83.64) 49 (84.48) 37 (84.09) 284 (81.84) 0.771
Intestine 43 (79.63) 44 (72.13) 38 (67.86) 37 (68.52) 37 (69.81) 49 (67.12) 39 (73.58) 287 (71.04) 0.385
Liver 22 (73.33) 25 (78.13) 20 (64.52) 27 (71.05) 31 (64.58) 24 (72.73) 26 (66.67) 175 (79.72) 0.435
Open in a new tab

Abbreviation: AKI-D, acute kidney injury requiring dialysis.

Table S3.

The risk factors of short- and long-term mortality in surgical patients

Risk factors Short-term mortality
Long-term mortality
Parameter estimate Hazard ratio (95% CI) Parameter estimate Hazard ratio (95% CI)
AKI-D 1.7638 5.83 (5.38–6.32) 1.2845 3.61 (3.37–3.87)
Acute respiratory distress syndrome 1.2702 3.56 (3.17–4.00) 1.0597 2.89 (2.64–3.16)
Repeat intubation 1.1378 3.12 (2.48–3.92) 0.6363 1.89 (1.54–2.31)
Hypovolemic shock 0.932 2.54 (2.27–2.84) 0.7595 2.14 (1.95–2.34)
Chest tube insertion 0.4487 1.57 (1.40–1.75) 0.2963 1.34 (1.23–1.47)
Stroke 0.3789 1.46 (1.16–1.83) 0.3096 1.36 (1.15–1.62)
Hemopericardium 0.3428 1.41 (1.08–1.84) –
GI bleeding 0.1861 1.20 (1.06–1.37) –
Severe sepsis 0.1387 1.15 (1.04–1.26) –
Rheumatologic disease – 0.2498 1.28 (1.00–1.64)
Charlson comorbidity index score 0.1399 1.15 (1.13–1.18) 0.1365 1.15 (1.12–1.18)
Malignancy – 0.1681 1.18 (1.02–1.37)
Liver disease – 0.1105 1.12 (1.00–1.24)
Sex 0.091 1.10 (1.01–1.19) 0.105 1.11 (1.04–1.18)
Age 0.0142 1.01 (1.01–1.02) 0.0205 1.02 (1.02–1.02)
Open in a new tab

Abbreviations: –, not applicable; AKI-D, acute kidney injury requiring dialysis; GI, gastrointestinal.

Table S4.

CTS and non-CTS patients matched

The matched parameters CTS n=79 Non-CTS n=154 SMD Propensity score-matched
CTS n=72 Non-CTS n=72 SMD
Male sex 51 (64.56%) 109 (70.78%) 0.063 48 (66.67%) 47 (65.28%) 0.029
Age 66.36±14.59 65.41±15.75 0.133 65.50±14.59 66.89±15.21 0.093
Charlson comorbidity index score 6.20±3.04 6.31±3.20 0.033 6.14±3.10 6.24±3.22 0.031
APACHE II score 21.81±7.61 23.01±6.31 0.171 21.86±7.89 22.14±6.38 0.039
SOFA score 12.53±3.96 12.31±3.92 0.056 12.29±3.87 12.25±3.55 0.011
Open in a new tab

Note: Data presented as n (%) or mean ± SD.

Abbreviations: APACHE II, acute physiology and chronic health evaluation II; CTS, cardiothoracic surgery; SMD, standardized mean difference; SOFA, sequential organ failure assessment.

Acknowledgments

We would like to express our profound respect and sincere appreciation with deep sense of gratitude to Professor Lik-wang Chen, Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan, for her kindness of supplying the data. We also would like to thank Professor Fu-Chang Hu, Graduate Institute of Clinical Medicine and School of Nursing, National Taiwan University College of Medicine, Taipei, Taiwan, for his professional help of detailed statistical analysis. The study is partly based on data provided by Bureau of National Health Insurance, Department of Health, Taiwan. The interpretation and conclusions shown in this paper do not represent those of Bureau of National Health Insurance, Department of Health, National Health Research Institutes, or National Taiwan University Hospital. This study was supported by the Taiwan National Science Council grants 103-2314-B-002-026, 104-2314-B-002-130, 104-2314-B-002-125-MY3, 105-2314-B-002-045 and National Taiwan University Hospital 106-S3466, 106-FTN20, 106-P02, UN106-014, 106-S3582, 105-M3195, 105-P05, VN105-04, 105-S3061, VN104-07, 104-S2718. This study was also supported by Ta-Tung Kidney Foundation, and the Mrs Hsiu- Chin Lee Kidney Research Foundation, Taipei, Taiwan. We thank the staff of the Eighth Core Lab, Department of Medical Research, National Taiwan University Hospital for technical support during the study. We also appreciate and thank all the members of the Taiwan Clinical Trial Consortium, TCTC grant MOST 106-2321-B-182-002, 105-2314-B-002-045, which are listed in alphabetical order of their affiliation names: Cardinal Tien Hospital: Kuo-Cheng Lu; Chi-Mei Medical Center, Liouying: Jian-Jhong Wang; Chi-Mei Medical Center, Yongkang: Wei-Chih Kan; China Medical University Hospital: Chiu-Ching Huang, Che-Yi Chou, Ya-Fei Yang; Dalin Tzu-Chi Hospital: Jen-Pi Tsai; Far Eastern Memorial Hospital: Hung-Yuan Chen; International-Harvard Statistical Consulting Company: Fu-Chang Hu; Kaohsiung Chang Gung Memorial Hospital: Chien-Te Lee, Jin-Bor Chen, Chih-Hsiung Lee, Wen-Chin Lee, Lung-Chih Li, Te-Chuan Chen; Kaohsiung Municipal Ta-Tung Hospital: Hugo You-Hsien Lin; Keelung Chang Gung Memorial Hospital: Chin-Chan Lee, Chiao-Yin Sun, MD, Heng-Chih Pan; Linkou Chang Gung Memorial Hospital: Yung-Chang Chen, Ming-Yang Chang, Chang-Chyi Jenq, Chan-Yu Lin, Chih-Hsiang Chang, Tsung-Yu Tsai; Lin-Shin Hospital: Cheng-Min Chen; Lotung Poh-Ai Hospital: En-Tzu Lin; Luodong Saint Mary’s Hospital: Chih-Chung Shiao; Mackay Memorial Hospital: Chih-Jen Wu, Cheng-Jua Lin; Mackay Memorial Hospital Taitung Branch: Feng-Chi Kuo; Mennonite Christian Hospital: I-Chieh Tsai; Min-Sheng General Hospital: Chih-Jen Weng; National Health Research Institutes: LiKwang Chen; National Taiwan University Hospital: Kwan-Dun Wu, Tzong-Shinn Chu, Shuei-Liong Lin, MD, PhD, Vin-Cent Wu, Chun-Fu Lai; National Taiwan University Hospital Bei-Hu Branch: Tai-Shuan Lai; National Taiwan University Hospital Hsin Chu Branch: Wei-Shun Yang; National Taiwan University Hospital Yun-Lin Branch: Yung-Ming Chen, Tao-Min Huang; New Taipei City Hospital Sanchong Branch: Wen-Ding Hsu; Shin-Kong Wo Ho-Su Memorial Hospital: Jyh-Gang Leu, Jui-Ting Chang; Sin-Ren Hospital: Hung-Hsiang Liou; Taichung Veteran General Hospital: Kuo-Hsiung Hsu, Ming-Ju Wu, Chun-Te Huang; Taichung Veteran General Hospital Chiayi Branch: Zi-hong You; Taipei City Hospital Heping Branch: Chao-Fu Chang; Taipei Medical University Hospital: Tzen-Wen Chen, Hsi-Hsien Chen, Fan-Chi Chang, Yen-Chung Lin, Mai-Szu Wu, Chih-Chin Kao; Taipei Tzu Chi Hospital: Szu-Chun Hung, Ko-Lin Kuo, Che-Hsiung Wu; Taipei Veterans General Hospital: Der-Cherng Tarng, Kuo-Hua Lee; Taoyuan General Hospital, Ministry of Health and Welfare: Wei-Jie Wang, Jui-Hsiang Lin. We especially thank Professor Ji-Tseng Fang, Chang Gung University Col lege of Medicine, Taoyuan, Taiwan; Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Taiwan, for his extraordinary work and leadership skills in establishing CAKS cohort.

Footnotes

Disclosure

The authors report no conflicts of interest in this work.

References

  • 1.Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10(3):R73. doi: 10.1186/cc4915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mandelbaum T, Scott DJ, Lee J, et al. Outcome of critically ill patients with acute kidney injury using the Acute Kidney Injury Network criteria. Crit Care Med. 2011;39(12):2659–2664. doi: 10.1097/CCM.0b013e3182281f1b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bellomo R. Acute renal failure. Semin Respir Crit Care Med. 2011;32(5):639–650. doi: 10.1055/s-0031-1287872. [DOI] [PubMed] [Google Scholar]
  • 4.Thakar CV. Perioperative acute kidney injury. Adv Chronic Kidney Dis. 2013;20(1):67–75. doi: 10.1053/j.ackd.2012.10.003. [DOI] [PubMed] [Google Scholar]
  • 5.Kim CS, Oak CY, Kim HY, et al. Incidence, predictive factors, and clinical outcomes of acute kidney injury after gastric surgery for gastric cancer. PLoS One. 2013;8(12):e82289. doi: 10.1371/journal.pone.0082289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lee EH, Kim HR, Baek SH, et al. Risk factors of postoperative acute kidney injury in patients undergoing esophageal cancer surgery. J Cardiothorac Vasc Anesth. 2014;28(4):936–942. doi: 10.1053/j.jvca.2013.12.006. [DOI] [PubMed] [Google Scholar]
  • 7.Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365–3370. doi: 10.1681/ASN.2004090740. [DOI] [PubMed] [Google Scholar]
  • 8.Hobson C, Ozrazgat-Baslanti T, Kuxhausen A, et al. Cost and mortality associated with postoperative acute kidney injury. Ann Surg. 2015;261(6):1207–1214. doi: 10.1097/SLA.0000000000000732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Nisula S, Kaukonen KM, Vaara ST, et al. Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study. Intensive Care Med. 2013;39(3):420–428. doi: 10.1007/s00134-012-2796-5. [DOI] [PubMed] [Google Scholar]
  • 10.Srisawat N, Lawsin L, Uchino S, Bellomo R, Kellum JA, BEST Kidney Investigators Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study. Crit Care. 2010;14(2):R46. doi: 10.1186/cc8933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Parikh A, Shaw A. The economics of renal failure and kidney disease in critically ill patients. Crit Care Clin. 2012;28(1):99–111. doi: 10.1016/j.ccc.2011.10.006. [DOI] [PubMed] [Google Scholar]
  • 12.Lin YF, Ko WJ, Chu TS, et al. The 90-day mortality and the subsequent renal recovery in critically ill surgical patients requiring acute renal replacement therapy. Am J Surg. 2009;198(3):325–332. doi: 10.1016/j.amjsurg.2008.10.021. [DOI] [PubMed] [Google Scholar]
  • 13.Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):442–448. doi: 10.1038/ki.2011.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Doi K, Rabb H. Impact of acute kidney injury on distant organ function: recent findings and potential therapeutic targets. Kidney Int. 2016;89(3):555–564. doi: 10.1016/j.kint.2015.11.019. [DOI] [PubMed] [Google Scholar]
  • 15.Bihorac A, Brennan M, Ozrazgat-Baslanti T, et al. National surgical quality improvement program underestimates the risk associated with mild and moderate postoperative acute kidney injury. Crit Care Med. 2013;41(11):2570–2583. doi: 10.1097/CCM.0b013e31829860fc. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ingraham AM, Richards KE, Hall BL, Ko CY, Cy K. Quality improvement in surgery: the American College of Surgeons National Surgical Quality Improvement Program approach. Adv Surg. 2010;44:251–267. doi: 10.1016/j.yasu.2010.05.003. [DOI] [PubMed] [Google Scholar]
  • 17.Cohen ME, Ko CY, Bilimoria KY, et al. Optimizing ACS NSQIP modeling for evaluation of surgical quality and risk: patient risk adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus. J Am Coll Surg. 2013;217346(2):336–346. doi: 10.1016/j.jamcollsurg.2013.02.027. [DOI] [PubMed] [Google Scholar]
  • 18.Cohen ME, Liu Y, Ko CY, Hall BL. Improved surgical outcomes for ACS NSQIP hospitals over time: evaluation of hospital cohorts with up to 8 years of participation. Ann Surg. 2016;263(2):267–273. doi: 10.1097/SLA.0000000000001192. [DOI] [PubMed] [Google Scholar]
  • 19.Ho Chan WS. Taiwan’s healthcare report 2010. EPMA J. 2010;1(4):563–585. doi: 10.1007/s13167-010-0056-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wu VC, Wu CH, Huang TM, et al. Long-term risk of coronary events after AKI. J Am Soc Nephrol. 2014;25(3):595–605. doi: 10.1681/ASN.2013060610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wu CS, Lai MS, Gau SS, Wang SC, Tsai HJ. Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan. PLoS One. 2014;9(12):e112257. doi: 10.1371/journal.pone.0112257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353(4):349–361. doi: 10.1056/NEJMoa041895. [DOI] [PubMed] [Google Scholar]
  • 23.Shiao CC, Wu PC, Wu VC, et al. Nationwide epidemiology and prognosis of dialysis-requiring acute kidney injury (NEP-AKI-D) study: design and methods. Nephrology. 2016;21(9):758–764. doi: 10.1111/nep.12670. [DOI] [PubMed] [Google Scholar]
  • 24.Grams ME, Sang Y, Coresh J, et al. Acute kidney injury after major surgery: a retrospective analysis of veterans health administration data. Am J Kidney Dis. 2016;67(6):872–880. doi: 10.1053/j.ajkd.2015.07.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Mishra PK, Luckraz H, Nandi J, et al. Long-term quality of life post-acute kidney injury in cardiac surgery patients. Ann Card Anaesth. 2018;21(1):41–45. doi: 10.4103/aca.ACA_104_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496–509. [Google Scholar]
  • 27.Stone AB, Yuan CT, Rosen MA, et al. Barriers to and facilitators of implementing enhanced recovery pathways using an implementation framework: a systematic review. JAMA Surg. 2018;153(3):270. doi: 10.1001/jamasurg.2017.5565. [DOI] [PubMed] [Google Scholar]
  • 28.Siew ED, Davenport A. The growth of acute kidney injury: a rising tide or just closer attention to detail? Kidney Int. 2015;87(1):46–61. doi: 10.1038/ki.2014.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Siddiqui NF, Coca SG, Devereaux PJ, et al. Secular trends in acute dialysis after elective major surgery – 1995 to 2009. CMAJ. 2012;184(11):1237–1245. doi: 10.1503/cmaj.110895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lenihan CR, Montez-Rath ME, Mora Mangano CT, Chertow GM, Winkelmayer WC. Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008. Ann Thorac Surg. 2013;95(1):20–28. doi: 10.1016/j.athoracsur.2012.05.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative Workgroup Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204–212. doi: 10.1186/cc2872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31. doi: 10.1186/cc5713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kolhe NV, Muirhead AW, Wilkes SR, Fluck RJ, Taal MW. National trends in acute kidney injury requiring dialysis in England between 1998 and 2013. Kidney Int. 2015;88(5):1161–1169. doi: 10.1038/ki.2015.234. [DOI] [PubMed] [Google Scholar]
  • 34.Bihorac A. Acute kidney injury in the surgical patient: recognition and attribution. Nephron. 2015;131(2):118–122. doi: 10.1159/000439387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Ishani A, Nelson D, Clothier B, et al. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med. 2011;171(3):226–233. doi: 10.1001/archinternmed.2010.514. [DOI] [PubMed] [Google Scholar]
  • 36.Bagshaw SM, Cruz DN, Aspromonte N, et al. Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant. 2010;25(5):1406–1416. doi: 10.1093/ndt/gfq066. [DOI] [PubMed] [Google Scholar]
  • 37.VA/NIH Acute Renal Failure Trial Network. Palevsky PM, Zhang JH, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7–20. doi: 10.1056/NEJMoa0802639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Wald R, Mcarthur E, Adhikari NK, et al. Changing incidence and outcomes following dialysis-requiring acute kidney injury among critically ill adults: a population-based cohort study. Am J Kidney Dis. 2015;65(6):870–877. doi: 10.1053/j.ajkd.2014.10.017. [DOI] [PubMed] [Google Scholar]
  • 39.Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation. 1997;95(4):878–884. doi: 10.1161/01.cir.95.4.878. [DOI] [PubMed] [Google Scholar]
  • 40.Chawla LS, Goldstein SL, Kellum JA, Ronco C. Renal angina: concept and development of pretest probability assessment in acute kidney injury. Crit Care. 2015;19:93. doi: 10.1186/s13054-015-0779-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.O’Neal JB, Shaw AD, Billings FT, Ftt B. Acute kidney injury following cardiac surgery: current understanding and future directions. Crit Care. 2016;20(1):187. doi: 10.1186/s13054-016-1352-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Chen YC, Su YC, Lee CC, Huang YS, Hwang SJ. Chronic kidney disease itself is a causal risk factor for stroke beyond traditional cardiovascular risk factors: a nationwide cohort study in Taiwan. PLoS One. 2012;7(4):e36332. doi: 10.1371/journal.pone.0036332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Dignam JJ, Zhang Q, Kocherginsky M. The use and interpretation of competing risks regression models. Clin Cancer Res. 2012;18(8):2301–2308. doi: 10.1158/1078-0432.CCR-11-2097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Wolbers M, Blanche P, Koller MT, Witteman JC, Gerds TA. Concordance for prognostic models with competing risks. Biostatistics. 2014;15(3):526–539. doi: 10.1093/biostatistics/kxt059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312(25):1604–1608. doi: 10.1056/NEJM198506203122504. [DOI] [PubMed] [Google Scholar]
  • 46.Fair allocation of intensive care unit resources. American Thoracic Society. Am J Respir Crit Care Med. 1997;156(4 Pt 1):1282–1301. doi: 10.1164/ajrccm.156.4.ats7-97. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Figure S1

The trend of yearly AKI-D incidence in 106,573 surgical patients and an annually adjusted hazard ratio of 30-day and long-term mortality in 1,861 surgical AKI-D patients, stratified by the surgical type.

Notes: The annual incidence of AKI-D was shown in (A) and was compared in different surgical types in (B). The adjusted hazard ratio of 30-day mortality of surgical AKI-D patients was shown in (C) and was compared in different surgical types in (D), while the adjusted hazard ratio of long-term mortality of surgical AKI-D patients was shown in (E) and was compared in different surgical types in (F). The incidence of AKI-D increased from 1.16% in 2001 to 1.75% in 2007 (trend P≤0.001) (Figure S1A). The adjusted hazard ratio for 30-day mortality increased from 7.7 (95% CI 6.35–9.35) in 2001 to 9.19 (95% CI 7.82–10.9) in 2007 (Figure S1C), and long-term mortality increased from 7.2 (95% CI 6.12–8.48) in 2001 to 10.04 (95% CI 8.69–11.61) in 2007 (Figure S1E). Post-CTS patients had a higher incidence of AKI-D compared with non-CTS patients (Figure S1B). However, the 30-day and long-term mortality were higher in non-CTS patients (Figure S1D and F). **P<0·001.

Abbreviations: AKI-D, acute kidney injury requiring dialysis; CTS, cardiothoracic surgery.

clep-10-1583s1.tif (492.6KB, tif)
Figure S2

The standardized mean difference (SMD) of the variables before and after the propensity score matching. After the matching, the SMD of all variables was <0.1.

Abbreviations: CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; ECMO, extracorporeal membrane oxygenation; GI, gastrointestinal.

clep-10-1583s2.tif (281.1KB, tif)

Table S1.

Factors identified as predictors of AKI-D during index admission for the propensity score matchinga

Predictive variables Odds ratio (95% CI) P-value
Advanced CKD 32.740 (20.191–53.509) <0.001b
Cardiac arrest 5.115 (1.966–12.221) <0.001b
Use of ECMO 4.993 (4.236–5.890) <0.001b
Acute respiratory distress syndrome 4.860 (4.240–5.567) <0.001b
Hypovolemic shock 3.472 (2.944–4.083) <0.001b
Hospital stay length 3.320 (2.961–3.722) <0.001b
Repeat intubation 1.733 (1.123–2.622) 0.011b
Chest tube insertion 1.691 (1.443–1.976) <0.001b
Severe sepsis 1.624 (1.341–1.963) <0.001b
Rheumatologic disease 1.621 (1.023–2.466) 0.031b
Hemopericardium 1.449 (0.973–2.099) 0.058
Prolonged mechanical ventilation 1.397 (1.254–1.556) <0.001b
GI bleeding 1.382 (1.120–1.694) 0.002b
Charlson comorbidity index score 1.307 (1.235–1.383) <0.001b
Diabetes 1.279 (1.112–1.471) 0.001b
Surgical type (CVS vs others) 1.200 (1.034–1.389) 0.016b
Sex 1.101 (0.989–1.226) 0.079
Age 1.009 (1.005–1.012) <0.001b
Pneumonia 0.832 (0.692–0.998) 0.049b
Pleural effusion 0.734 (0.560–0.950) 0.022b
Myocardial infarction 0.693 (0.539–0.884) 0.004b
Atrial fibrillation 0.687 (0.530–0.879) 0.004b
Cerebrovascular disease 0.623 (0.502–0.767) <0.001b
Chronic obstructive pulmonary disease 0.563 (0.474–0.666) <0.001b
Dementia 0.557 (0.373–0.806) 0.003b
Hemiplegia or paraplegia 0.330 (0.135–0.698) 0.007b
Malignancy 0.328 (0.236–0.452) <0.001b
Open in a new tab

Notes:

a

Goodness of fit test: variance inflation faction of all factors (all <2); adjust generalized R2=0.295; area under the receiver operating characteristic curve=0.906 (0.899–0.913); this model does not pass the modified Hosmer–Lemeshow test.

b

P<0.05.

Abbreviations: AKI-D, acute kidney injury requiring dialysis; CKD, chronic kidney disease; CVS, cardiovascular surgery; ECMO, extra-corporeal membrane oxygenation; GI, gastrointestinal.

Table S2.

Incidence of AKI-D and its related crude mortality in 106,573 surgical patients stratified by four major surgeries

Patients Surgery type 2001 2002 2003 2004 2005 2006 2007 Total P for trend
Patient numbers All 14,424 14,886 13,615 15,328 15,775 16,212 16,333 106,573
Cardiothoracic 2,037 2,120 1,937 2,969 3,738 3,753 3,781 20,335
Esophagus 2,964 3,123 2,909 2,663 2,315 2,194 2,100 18,268
Intestine 3,644 3,962 3,700 3,920 4,082 4,142 4,207 27,657
Liver 5,779 5,681 5,069 5,776 5,640 6,123 6,245 40,313
AKI-D, n (%) All 167 (1.16) 196 (1.32) 194 (1.43) 249 (1.62) 344 (2.18) 376 (2.32) 335 (2.05) 1,861 (1.75)
Cardiothoracic 30 (1.47) 60 (2.83) 50 (2.58) 120 (4.04) 188 (5.03) 212 (5.65) 199 (5.26) 859 (4.22) <0.001
Esophagus 53 (1.79) 43 (1.38) 57 (1.96) 37 (1.39) 55 (2.38) 58 (2.64) 44 (2.10) 347 (1.90) 0.008
Intestine 54 (1.48) 61 (1.54) 56 (1.51) 54 (1.38) 53 (1.30) 73 (1.76) 53 (1.26) 404 (1.46) 0.661
Liver 30 (0.52) 32 (0.56) 31 (0.61) 38 (0.66) 48 (0.85) 33 (0.54) 39 (0.62) 251 (0.62) 0.378
Mortality in AKI-D, n (%) All 133 (79.64) 132 (67.35) 134 (69.07) 161 (64.66) 224 (65.12) 244 (64.89) 218 (65.07) 1246 (66.95)
Cardiothoracic 22 (73.33) 30 (50.00) 30 (60.00) 70 (58.33) 110 (58.51) 122 (57.55) 116 (58.29) 500 (58.21) 0.789
Esophagus 46 (86.79) 33 (76.74) 46 (80.70) 27 (72.97) 46 (83.64) 49 (84.48) 37 (84.09) 284 (81.84) 0.771
Intestine 43 (79.63) 44 (72.13) 38 (67.86) 37 (68.52) 37 (69.81) 49 (67.12) 39 (73.58) 287 (71.04) 0.385
Liver 22 (73.33) 25 (78.13) 20 (64.52) 27 (71.05) 31 (64.58) 24 (72.73) 26 (66.67) 175 (79.72) 0.435
Open in a new tab

Abbreviation: AKI-D, acute kidney injury requiring dialysis.

Table S3.

The risk factors of short- and long-term mortality in surgical patients

Risk factors Short-term mortality
Long-term mortality
Parameter estimate Hazard ratio (95% CI) Parameter estimate Hazard ratio (95% CI)
AKI-D 1.7638 5.83 (5.38–6.32) 1.2845 3.61 (3.37–3.87)
Acute respiratory distress syndrome 1.2702 3.56 (3.17–4.00) 1.0597 2.89 (2.64–3.16)
Repeat intubation 1.1378 3.12 (2.48–3.92) 0.6363 1.89 (1.54–2.31)
Hypovolemic shock 0.932 2.54 (2.27–2.84) 0.7595 2.14 (1.95–2.34)
Chest tube insertion 0.4487 1.57 (1.40–1.75) 0.2963 1.34 (1.23–1.47)
Stroke 0.3789 1.46 (1.16–1.83) 0.3096 1.36 (1.15–1.62)
Hemopericardium 0.3428 1.41 (1.08–1.84) –
GI bleeding 0.1861 1.20 (1.06–1.37) –
Severe sepsis 0.1387 1.15 (1.04–1.26) –
Rheumatologic disease – 0.2498 1.28 (1.00–1.64)
Charlson comorbidity index score 0.1399 1.15 (1.13–1.18) 0.1365 1.15 (1.12–1.18)
Malignancy – 0.1681 1.18 (1.02–1.37)
Liver disease – 0.1105 1.12 (1.00–1.24)
Sex 0.091 1.10 (1.01–1.19) 0.105 1.11 (1.04–1.18)
Age 0.0142 1.01 (1.01–1.02) 0.0205 1.02 (1.02–1.02)
Open in a new tab

Abbreviations: –, not applicable; AKI-D, acute kidney injury requiring dialysis; GI, gastrointestinal.

Table S4.

CTS and non-CTS patients matched

The matched parameters CTS n=79 Non-CTS n=154 SMD Propensity score-matched
CTS n=72 Non-CTS n=72 SMD
Male sex 51 (64.56%) 109 (70.78%) 0.063 48 (66.67%) 47 (65.28%) 0.029
Age 66.36±14.59 65.41±15.75 0.133 65.50±14.59 66.89±15.21 0.093
Charlson comorbidity index score 6.20±3.04 6.31±3.20 0.033 6.14±3.10 6.24±3.22 0.031
APACHE II score 21.81±7.61 23.01±6.31 0.171 21.86±7.89 22.14±6.38 0.039
SOFA score 12.53±3.96 12.31±3.92 0.056 12.29±3.87 12.25±3.55 0.011
Open in a new tab

Note: Data presented as n (%) or mean ± SD.

Abbreviations: APACHE II, acute physiology and chronic health evaluation II; CTS, cardiothoracic surgery; SMD, standardized mean difference; SOFA, sequential organ failure assessment.

Articles from Clinical Epidemiology are provided here courtesy of Dove Press

RESOURCES